Topiramate does not alter nicotine or cocaine discrimination in rats.

Abstract

The effects of topiramate, a potential treatment for drug dependence, were evaluated in two groups of rats trained to discriminate the administration of either 0.4 mg/kg nicotine or 10 mg/kg cocaine from that of saline, under a fixed-ratio 10 schedule of food delivery. Topiramate (1-60 mg/kg, intraperitoneal) did not produce any nicotine-like or cocaine-like discriminative effects by itself and did not produce any shift in the dose-response curves for nicotine or cocaine discrimination. Thus, the ability to discriminate the effects of nicotine or cocaine does not appear to be altered by topiramate administration. Furthermore, topiramate, given either alone or in combination with nicotine or cocaine, did not depress rates of responding. These experiments indicate that topiramate does not enhance or reduce the ability of rats to discriminate the effects of nicotine or cocaine.

• Authors: Bernard Le Foll, Zuzana Justinova, Carrie E Wertheim, Chanel Barnes, Steven R Goldberg
• Journal: Behavioural pharmacology (Behav Pharmacol) Vol. 19 Issue 1 Pg. 13-20 (Feb 2008) ISSN: 0955-8810 [Print] England
• PMID: 18195590 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)

Chemical References

• Anticonvulsants
• Dopamine Uptake Inhibitors
• Nicotinic Agonists
• Topiramate
• Fructose
• Nicotine
• Cocaine

Topics

• Animals
• Anticonvulsants (pharmacology)
• Cocaine (pharmacology)
• Discrimination, Psychological (drug effects)
• Dopamine Uptake Inhibitors (pharmacology)
• Dose-Response Relationship, Drug
• Fructose (administration & dosage, analogs & derivatives, pharmacology)
• Injections, Intraperitoneal
• Male
• Nicotine (pharmacology)
• Nicotinic Agonists (pharmacology)
• Rats
• Rats, Sprague-Dawley
• Topiramate